Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
Researchers and clinicians are increasingly aware of the importance of personalised medicine and treatment decisions being driven by knowledge of what treatments work for whom. Our data suggests an important role of the Patient Global Impression of Change in clinical trials as it may better reflect balance between symptoms reduction and side-effects and therefore be more useful in clinician-patients joint decision making.
Authors
- Ann Doust (ORCID: https://orcid.org/0000-0001-8726-7186)
- Katy Vincent (ORCID: https://orcid.org/0000-0001-9249-2492)
- JANE P. DANIELS (ORCID: https://orcid.org/0000-0003-3324-6771)
- Scott C. Mackenzie (ORCID: https://orcid.org/0000-0001-5823-4334)
- Lydia Coxon (ORCID: https://orcid.org/0000-0003-0818-1240)
- Andrew W. Horne (ORCID: https://orcid.org/0000-0002-9656-493X)
- Maryam Amer
Institutions
- University of Nottingham (GB)
- University of Oxford (GB)
- MRC Centre for Reproductive Health (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.3389/fphar.2024.1460206
- Citations
- 2
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- National Institute for Health and Care Research
- Medical Research Council